Category: Pharmacotherapy
-
-
Daily Cardiology Symposium 1405: Obesity Pharmacotherapy
August 17, 2026DCS 1405: Obesity Pharmacotherapy
-
Daily Cardiology Symposium 1405: Antianginal Pharmacotherapy
August 17, 2026DCS 1405: Antianginal Pharmacotherapy
-
Daily Cardiology Symposium 1405: Diabetes Pharmacotherapy
August 17, 2026DCS 1405: DM Pharmacotherapy
-
Daily Cardiology Symposium 1405: NOACs Pharmacotherapy
August 17, 2026DCS 1405: NOACs Pharmacotherapy
-
-
Daily Cardiology Symposium 1405: Dyslipidemia Pharmacotherapy
August 17, 2026DCS 1405: Dyslipidemia Pharmacotherapy
-
Daily Cardiology Symposium 1405: Antiplatelet Therapy
August 17, 2026DCS 1405: Antiplatelet Pharmacotherapy
-
Daily Cardiology Symposium 1405: Heart Failure Pharmacotherapy
August 17, 2026DCS 1405: HF Pharmacotherapy
-
Daily Cardiology Symposium 1405: Hypertension Pharmacotherapy
August 17, 2026DCS 1405: HTN Pharmacotherapy
-
Low versus high dose strategies of intravenous nitroglycerin for the management of sympathetic crashing acute pulmonary edema
August 11, 2026Low vs high-dose IV nitroglycerin in SCAPE management
-
-
-
-
-
-
-
-
-
-
-
-
ESC 2025 Guideline Overview: Cardiovascular Disease and Pregnancy
December 30, 2025ESC 2025 Cardiovascular Disease and Pregnancy Guideline
-
ESC 2025 Consensus overview: Mental Health and Cardiovascular Disease
December 30, 2025ESC 2025 Mental Heath and Cardiovascular Disease Consensus
-
A brief summary of the NEO-MINDSET trial and the HI-PRO trial
December 30, 2025The NEO-MINDSET trial and the HI-PRO trial
-
Summary of REBOOT, BETAMI, DANBLOCK, CAPITAL, and AQUATIC Trials
December 30, 2025Overview of REBOOT, BETAMI, DANBLOCK, CAPITAL, and AQUATIC RCTs
-
2024 AHA/ACC Guideline on the Management of Lower ExtremityPeripheral Artery Disease
December 3, 2025AHA clinical update
-
Save The Date: 26th H&H Academy Session
December 2, 2025Best Practice for Hypertension & Dyslipidemia Management on
-
Cardiosignal 89: Antithrombotic therapy three months after bioprosthetic AVR
November 26, 2025CardioSignal 89
-
-
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
November 9, 2025Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
-
Save The Date: 25th H&H Academy Session
November 7, 2025Best Practice for Hypertension & Dyslipidemia Management
-
-
-
Save The Date: 24th H&H Academy Session
October 29, 2025Best Practice for Hypertension & Dyslipidemia Management
-
Dapagliflozin in Patients Hospitalized for Heart Failure
October 14, 2025DAPA ACT HF-TIMI clinical trial
-
-
Outcomes of cardiovascular screening in men aged 60–64 years
October 13, 2025DANCAVAS II clinical trial
-
Daily Cardiology Symposium 1404: Hypertension
October 10, 2025DCS 1404: From Guideline to Action: HTN
-
Daily Cardiology Symposium 1404: Heart Failure
October 10, 2025DCS 1404: From Guideline to Action: HF
-
-
Daily Cardiology Symposium 1404: Peripheral Artery Disease
October 9, 2025DCS 1404: From Guideline to Action: PAD
-
Daily Cardiology Symposium 1404: Diabetes Mellitus
October 9, 2025DCS 1404: From Guideline to Action: DM
-
Daily Cardiology Symposium 1404: Atrial Fibrillation
October 9, 2025DCS 1404: From Guideline to Action: AF
-
Daily Cardiology Symposium 1404: Chronic Coronary Syndrome
October 9, 2025DCS 1404: From Guideline to Action: CCS
-
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
October 5, 2025ODYSSEY-HCM clinical trial
-
-
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
October 1, 2025BaxHTN clinical trial
-
Mastering the 2025 ACC/AHA hypertension guideline
September 25, 2025Review of 2025 ACC/AHA HTN guideline
-
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention
September 25, 2025TAILORED-CHIP clinical trial
-
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
September 25, 2025ALONE-AF clinical trial
-
Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias
September 23, 2025POTCAST clinical trial
-
C-reactive protein and cardiovascular risk among women with no standard modifiable risk factors
September 23, 2025SMuRF-less but inflamed
-
β-blockers after myocardial infarction with mildly reduced ejection fraction
September 23, 2025REBOOT-CNIC and BETAMI-DANBLOCK clinical trials
-
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
September 22, 2025DIGIT-HF Clinical Trial
-
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
September 20, 2025MAPLE-HCM Clinical Trial
-
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery
September 16, 2025NEWTON-CABG Clinical Trial
-
Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome
September 16, 2025TACSI Clinical Trial
-
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum
September 15, 2025VICTORIA and VICTOR Clinical Trials
-
Reduction of Antihypertensive Treatment in Nursing Home Residents
September 15, 2025RETREAT-FRAIL Clinical Trial
-
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults
September 12, 2025DANFLU-2 Clinical Trial
-
-
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction
September 10, 2025TARGET-FIRST Clinical Trial
-
-
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT
August 26, 2025FINEARTS-HF: Modes of Death in HFmrEF & HFpEF
-
Cardiosignal 87: BP Goal in Patients with Hypertension During Pregnancy
August 24, 2025CardioSignal 87
-
-
Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of DOACs
August 16, 2025Thrombolysis after recent DOAC intake
-
-
-
-
Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients
July 23, 2025Case Discussion 125: DVT Prophylaxis
-
-
-
SGLT2 inhibitors in CKD: are they really effective in all patients?
July 13, 2025SGLT2 inhibitors in CKD
-
-
DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
July 8, 2025DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
-
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis
June 29, 2025Case Discussion 124: Anticoagulation in MS without AF
-
-
-
-
-
-
-
14th ACC 2025 Congress Coverage: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y
May 28, 202514th ACC 2025: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y
-
-
-
-
-
-
-
-
-
-
-
GAME-CHANGERS IN FOCUS، A Quiz on Landmark Trials of 2024
April 15, 2025Quiz of 2024 landmark Trials
-
-
-
5th Umbrella: Antithrombotic Therapy in Venous Thromboembolism
March 25, 2025Antithrombotic Therapy in VTE
-
5th Umbrella: Antithrombotic Therapy in Atrial Fibrillation
March 25, 2025Antithrombotic Therapy in AF
-
5th Umbrella: Antithrombotic Therapy in Chronic Coronary Syndrome
March 25, 2025Antithrombotic Therapy in CCS
-
5th Umbrella: Antithrombotic Therapy in Acute Coronary Syndrome
March 25, 2025Antithrombotic Therapy in ACS
-
-
-
-
-
-
-
16th AHA 2024 Congress Coverage: ALPACAR-360 Trial
February 1, 202516th AHA 2024: ALPACAR-360 Trial
-
-
-
-
Daily Cardiology 5th Umbrella: The Art of Antithrombotic Therapy In Daily Cardiovascular Practice
January 26, 20255th Umbrella: Antithrombotic Therapy
-
-
-
-
Cardiosignal 83, Antithrombotic therapy Post PCI in CCS patients with an indication for OAC
January 19, 2025Cardiosignal 83
-
-
-
6th AHA 2024 Congress Coverage: Nexiguran Ziclumeran for ATTR Cardiomyopathy
January 19, 20256th AHA 2024: ATTR Cardiomyopathy
-
-
-
-
-
-
Case Discussion 122: Antiarrhythmic and Anticoagulant Therapy After AF Ablation
January 1, 2025Case Discussion 122: Medications after AF Ablation
-
Case Discussion 120: VTE prophylaxis in a CAD patient on ASA, after TKA
December 30, 2024Case Discussion 120: VTE prophylaxis
-
Case Discussion 119: CAC Score Guide in Aspirin and Statin Therapy
December 30, 2024Case Discussion 119: CAC Score
-
1st AHA 2024 Congress Coverage: CLEAR SYNERGY (OASIS 9) Trial, Colchicine
December 25, 20241st AHA 2024: OASIS 9 Trial
-
-
Case Discussion 118: Omalizumab in patient with cardivascular disease
December 22, 2024Case Discussion 118: Omalizumab in CVD
-
Introduction of Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 18, 2024Intro of H&H Academy for non-physician healthcare providers
-
2nd Cardiology Online Grand Round: Invasive and Pharmacologic Approach to NSTE-ACS
December 17, 2024Online Grand Round: Approach to NSTE-ACS
-
Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
December 2, 2024H&H Academy for non-physician healthcare providers
-
-
Cardiosignal 81, changing Enalapril to an ARNI in a HErEF Patient with ESRD
November 23, 2024Cardiosignal 81
-
Save The Date: 2nd Cardiology Online Grand Round
November 19, 2024Save The Date: 2nd Cardiology Online Grand Round
-
Cardiosignal 79, Antithrombotic therapy post PCI in CCS patients with an indication for OAC
November 10, 2024Cardiosignal 79
-
-
-
-
-
-
-
-
-
34th ESC 2024 Congress Coverage: De-escalation to ticagrelor monotherapy vs. 12 months of dual antiplatelet therapy
October 16, 202434th ESC 2024: Ticagrelor monotherapy vs. dual antiplatelet therapy
-
31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3)
October 13, 202431st ESC 2024: ESC 2024 CCS Guideline (3)
-
30th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (2)
October 12, 202430th ESC 2024: ESC 2024 CCS Guideline (2)
-
28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1)
October 12, 202428th ESC 2024: ESC 2024 CCS Guideline (1)
-
26th ESC 2024 Congress Coverage: Lowering of non–high-density lipoprotein cholesterol after Myocardial Infarction
October 9, 202426th ESC 2024: ILowering of non-HDL cholesterol after MI and prognosis
-
-
-
-
20th ESC 2024 Congress Coverage: OCEANIC-AF Trial
September 30, 202420th ESC 2024: OCEANIC-AF Trial
-
19th ESC 2024 Congress Coverage: Stop-or-Not Trial
September 30, 202419th ESC 2024: Stop-or-Not Trial
-
17th ESC 2024 Congress Coverage: Sudden Cardiac Death
September 30, 2024Among Persons with Diabetes Aged 1–49 years
-
-
-
9th ESC 2024 Congress Coverage: BedMed and BedMed-Frail Trials
September 18, 20249th ESC 2024: BedMed and BedMed-Frail Trials
-
-
6th ESC 2024 Congress Coverage: Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
September 18, 20246th ESC 2024: Vutrisiran
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1403: Antithrombotics in Preventive Cardiology
July 17, 2024DCS 1403: Antithrombotics
-
-
-
-
-
-
Case Discussion 117 Answer: VTE prophylaxis in acutely ill hospitalized medical patients
June 19, 2024Case Discussion 117 Answer: VTE prophylaxis in hospitalized patients
-
-
-
-
-
-
ACC.24 Congress Coverage: Superiority Trial of Enalapril to Prevent Anthracycline-induced Cardiotoxicity
May 7, 2024ACC.24: PROACT Trial
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
ACC.24 Congress Coverage: Empagliflozin after Acute Myocardial Infarction
May 5, 2024ACC.24: EMPACT-AMI trial
-
ACC.24 Congress Coverage: Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care
April 30, 2024ACC.24: KARDIA-2 trial
-
ACC.24 Congress Coverage: Safety and Efficacy of Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
April 27, 2024ACC.24: IMPROVE-HCM trial
-
ACC.24 Congress Coverage: Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
April 27, 2024ACC.24: REDUCE-IT trial
-
ACC.24 Congress Coverage: An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
April 27, 2024ACC.24: VICTORION-INITIATE trial
-
ACC.24 Congress Coverage: A Technology-Assisted Web Application for Consumer Access to a Nonprescription Statin Medication
April 22, 2024ACC.24: TACTiC Trial
-
ACC.24 Congress Coverage: Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
April 17, 2024Infarction ACC.24: AEGIS-II Trial
-
ACC.24 Congress Coverage: Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
April 17, 2024ACC.24: ARISE-HF Trial
-
ACC.24 Congress Coverage: Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
April 17, 2024ACC.24: SGLT2i in ACHD
-
ACC.24 Congress Coverage: Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
April 17, 2024ACC.24: Bridge TIMI 73a Trial
-
ACC.24 Congress Coverage: The Trial to Assess Chelation Therapy 2
April 16, 2024ACC.24: TACT 2 Trial
-
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
April 16, 2024ACC.24: Semaglutide in HFpEF and DM
-
-
-
Case Discussion 115 Answer: Hormonal Contraceptive Medications in Patients with Hypertension
April 6, 2024Case Discussion 115 Answer: OCPs in Hypertensive patients
-
Case Discussion 111 Answer: Perioperative Management of Antiplatelet Medications in CCS Patients Undergoing CABG
April 6, 2024Case Discussion 111 Answer: Antiplatelet therapy before CABG in CCS patients
-
Impact: Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors
April 6, 2024Impact: Nitrates and PDE-5 inhibitors and Nitrates in CAD
-
Impact: Why Do GLP-1 Drugs Stop Working, and What to Do About It?
April 6, 2024Impact: GLP-1 agonists in the treatment of obesity
-
Cardiology Online Grand Round: The Art of Optimal Medical Therapy for Heart Failure
April 1, 2024Cardiology Online Grand Round: OMT in HF
-
Case Discussion 114 Answer: Cardiovascular considerations in patients receiving FLOT chemotherapy regimen
March 16, 2024Case Discussion 112 Answer: FLOT chemotherapy regimen and cardiovascular system
-
Light Rounds Volume 7: Elderly gentleman with HTN, ICMP and SCAF
March 16, 2024Light Round Volume 7: Approach to a patient with subclinical AF
-
Save The Date: Cardiology Online Grand Round
March 6, 2024Save The Date: Cardiology Online Grand Round
-
-
mpact: Cardiovascular and Non-cardiovascular Prescribing and Mortality After Takotsubo – Comparison With Myocardial Infarction and General Population
February 3, 2024Impact: Mortality After Takotsubo – Comparison With MI and General Population
-
Case Discussion 113 Answer: Considerations before initiating antihypertensive treatment
January 30, 2024Case Discussion 113 Answer: Choosing the best antihypertensive agent
-
Impact: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
January 20, 2024mpact: High Risk PE
-
Impact: Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention
January 20, 2024Impact: SAPT 1 year after PCI
-
Case Discussion 110 Answer: Tapering off and discontinuing medical therapy in acute idiopathic pericarditis
January 19, 2024Case Discussion 110 Answer: Medical therapy in acute pericarditis
-
Case Discussion 109 Answer: GI protection in patients on single antiplatelet therapy
January 16, 2024Case Discussion 109 Answer: GI protection in SAPT
-
-
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Pros by Dr. Hadaegh
January 6, 2024Diabeat 9th session, case based discussion
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons by Dr. Ghanavati
January 6, 2024Diabeat 9th session, case based discussion
-
-
Diabeat: the 9th diabetes masterclass for cardiologists, case-based discussion
December 30, 2023Diabeat 9th session, case based discussion
-
-
-
-
Case Discussion 98 Answer: Long term anticoagulation after cerebral venous sinus thrombosis
November 27, 2023Case Discussion 98 Answer: Anticoagulation after cerebral venous sinus thrombosis
-
AHA23 Congress Coverage: Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial
November 20, 2023A23 Congress Coverage: Lepodisiran Dose-Ascending Trial
-
AHA23 Congress Coverage: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation: ARTESIA trial
November 18, 2023AHA23 Congress Coverage: Apixaban in subclinical AF (ARTESIA)
-
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure: DAPA-MI trial
November 18, 2023AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
-
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: SELECT trial
November 18, 2023AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
-
AHA23 Congress Coverage: Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia: MINT trial
November 15, 2023AHA23 Congress Coverage: Blood Transfusion in MI and Anemia (MINT trial)
-
AHA23 Congress Coverage: Hypertension Treatment and Risk of Dementia
November 14, 2023AHA23 Congress Coverage: HTN and Dementia
-
Case Discussion 106: Approach to the diagnosis and management of asymptomatic hyperuricemia
November 13, 2023Case Discussion 102: asymptomatic hyperuricemia
-
-
-
Light Rounds Volume 6: Elderly gentleman with T2D, CAD and foot ulcer
October 15, 2023Light Round Volume 6: Approach to a patient with an ischemic foot ulcer
-
Light Rounds Volume 5: 22 Y/O lady with frequent PVCs
October 11, 2023Light Round Volume 5: Approach to a patient with frequent PVCs
-
Case Discussion 99: Choosing P2Y12 inhibitors in STEMI patients treated with Fibrinolytics and undergoing PCI
October 2, 2023Case Discussion 99: P2Y12 choice for PCI after fibrinolytic Tx
-
Impact: When Does a Calcium Score Equate to Secondary Prevention?
September 30, 2023Impact: New Evidence for Interpreting Calcium Score
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiomyopathies
September 17, 2023ESC 2023: New Cardiomyopathies Guideline
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
September 17, 2023ESC 2023: New DM and CVD Guideline
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of endocarditis
September 11, 2023ESC 2023: New Endocarditis Guideline
-
-
ESC 2023 Congress Coverage: 2023 Focused Update of the 2021 HF Guideline
September 9, 2023ESC 2023: HF Guideline Update
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Lost Puzzle In Diabetes Treatment: CAD and PAD in Patients with Diabetes
August 21, 2023CAD and PAD in DM
-
-
Impact: Clinical Outcomes of Calcium Channel Blockers versus Beta Blockers after Acute MI
August 20, 2023Impact: CCBs VS BBs post AMI
-
-
-
Impact: Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
August 14, 2023Impact: Zilebesiran
-
-
Impact: Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
August 12, 2023Impact: Anticoagulation in AF and stroke
-
-
-
Impact: Combination lipid-lowering therapy after PCI
August 1, 2023Impact: Dyslipidemia treatment after PCI
-
Daily Cardiology Symposium 1402 Day 2 Panel 4
July 25, 2023Infective Endocarditis and Prosthetic Valve Malfunction
-
Daily Cardiology Symposium 1402 Day 2 Panel 3
July 25, 2023Chronic Limb-Threatening Ischemia and Acute Aortic Syndromes
-
-
Daily Cardiology Symposium 1402 Day 2 Panel 1
July 25, 2023Acute Pericarditis and Cardiac Tamponade
-
Daily Cardiology Symposium 1402 Day 1 Panel 4
July 25, 2023Hypertension Crisis and Acute Hypertension in Pregnancy
-
Daily Cardiology Symposium 1402 Day 1 Panel 3
July 25, 2023Acute Coronary Syndrome and Acute Chest Pain
-
Daily Cardiology Symposium 1402 Day 1 Panel 2
July 25, 2023Acute De Novo Heart Failure and Cardiogenic Shock
-
Daily Cardiology Symposium 1402 Day 1 Panel 1
July 25, 2023Cardiopulmonary resuscitation and Narrow-complex Tachyarrhythmia
-
-
-
NEJM Knowledge plus Case Discussion
July 24, 2023a Case Discussion from NEJM Knowledge plus service
-
-
-
-
-
-
-
Vision: Adults with fasting TG=150-500mg with ASCVD or DM
July 3, 2023Vision: Mild hypertriglyceridemia in moderate to high risk patients
-
-
-
-
-
-
Cardiac considerations and monitoring in patients receiving Acetylcholinesterase inhibitors
June 12, 2023Acetylcholinesterase inhibitors' cardiac considerations
-
-
-
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
June 6, 2023Light Rounds 3: LV thrombus
-
-
-
-
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physician healthcare professionals
May 18, 2023H&H Academy: clinical tips for non-physicians
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
-
-
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
-
-
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
May 6, 2023Impact: Sacubitril/Valsartan and renal function in HF
-
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
-
Vision: Adults with fasting TG=150-500mg without ACVD or DM
April 15, 2023Vision: Mild hypertriglyceridemia in low-risk patients
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy: Smoothing the path to cardiovascular risk reduction
February 15, 2023H&H Academy: CVD risk reduction
-
-
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
January 21, 2023Case Discussion 70: Management of mild to moderate Hypokalemia
-
-
Impact: Management of ACS in older adults, an AHA statement
December 24, 2022Impact: ACS in the elderly
-
Case Discussion No. 68 Answer: anticoagulation in pregnancy
December 19, 2022Case Discussion No. 68 Answer
-
-
-
Impact: Dual antiplatelet therapy with Ticagrelor and graft failure after coronary artery bypass grafting
November 2, 2022Dual antiplatelet Tx. with Ticagrelor and graft failure after CABG
-
Impact: Acetaminophen in comparison to NSAIDs in cardiovascular diseases
October 31, 2022Impact: Acetaminophen vs. NSAIDs in CVD
-
Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrEF
October 16, 2022Impact: Sacubitril/Valsartan and MR severity in HFrEF
-
Impact: Effect of statin therapy on muscle symptoms
September 26, 2022Impact: Effect of statin therapy on muscle symptoms
-
-
-
-
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
September 18, 2022Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair
-
-
Save the date: Cardiorenal Metabolic Crossroads, 5th session
September 13, 2022Save the date: Cardiorenal Metabolic Crossroads, 5th session
-
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
September 13, 2022Umbrella: HF, Heart Failure with EF>40%
-
Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure
September 13, 2022Umbrella: HF, Acute Decompensated HF
-
Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF
September 13, 2022Umbrella: HF, Pharmacotherapy in HFrEF
-
Care Gaps in Adherence to Heart Failure Guidelines
September 12, 2022Care Gaps in Adherence to Heart Failure Guidelines
-
-
-
-
-
Save the date: Case-based discussion in patients with diabetes
August 30, 2022Save the date: Case-based discussion in patients with diabetes
-
-
-
-
-
-
-
-
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
Save the date: Hypertension and Hyperlipidemia Academy No. 10
August 18, 2022Save the date: H&H Academy No. 10
-
-
-
-
-
Cardio-Signal 51
August 5, 2022Management of antithrombotic therapy after prosthetic valve implantation
-
-
-
-
-
-
-
-
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals
July 19, 2022H&H Academy 10, for non-physician healthcare professionals
-
-
-
-
-
-
Save the date: Hypertension and Hyperlipidemia Academy, No. 9
June 28, 2022Save the date: The 9th H&H Academy
-
Daily Cardiology Symposium 1401, Day 2 Panel 4: Valvular heart disease
June 26, 2022DCS 1401: Valvular heart disease
-
-
-
-
-
Daily Cardiology Symposium 1401, Day 1 Panel 4: Peripheral vascular diseases
June 26, 2022DCS 1401: Peripheral vascular diseases
-
Daily Cardiology Symposium 1401, Day 1 Panel 3: Venous thromboembolism (VTE) prophylaxis
June 26, 2022DCS 1401: Venous thromboembolism (VTE) prophylaxis
-
Daily Cardiology Symposium 1401, Day 1 Panel 2: Revascularization in CAD
June 26, 2022DCS 1401: Revascularization in CAD
-
Daily Cardiology Symposium 1401, Day 1 Panel 1: Pharmacotherapy in CAD
June 26, 2022DCS 1401: Pharmacotherapy in CAD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
-
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
April 23, 2022Ticagrelor and secondary prevention in CCS
-
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
-
-
-
-
-
Familial hypercholesterolemia, a narrative review, part 2: diagnosis and screening
March 11, 2022FH 1: diagnosis and screening
-
-
-
-
-
-
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
March 8, 2022Umbrella: HTN, diagnosis and management of HTN
-
Save the date: Hypertension and Hyperlipidemia Academy 7
March 3, 2022Save the date: the 7th H&H Academy session
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
HeartCast 5: practical approach to the treatment of HFrEF
February 23, 2022The fifth HeartCast: HFrEF management
-
-
-
-
-
HeartCast 4: practical approach to the treatment of HFrEF
February 9, 2022The fourth HeartCast: HFrEF management
-
-
-
-
-
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
January 18, 2022H&H Academy: nurses and assistants
-
Familial hypercholesterolemia, a narrative review, part 1: definition and burden
January 14, 2022FH 1: Definition and burden
-
HeartCast 3: practical approach to the treatment of HFrEF
January 11, 2022The third HeartCast: HFrEF management
-
Hypertension and Hyperlipidemia Academy 5, a hybrid event
January 7, 20225th session of H&H Academy, online and onsite
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
January 2, 2022Umbrella H&S: session 4, secondary prevention of stroke
-
Umbrella Heart and Stroke: session 3, Atrial fibrillation screening
January 2, 2022Umbrella H&S: session 3, AF screening
-
Umbrella Heart and Stroke: session 2, carotid stenosis and stroke
January 2, 2022Umbrella H&S: session 2, carotid stenosis
-
Umbrella Heart and Stroke: session 1, detecting & managing patients with PFO
January 2, 2022Umbrella H&S: session1, PFO
-
HeartCast 2: practical approach to the treatment of HFrEF
December 29, 2021The second HeartCast: HFrEF management
-
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
December 29, 2021Rivaroxaban vs Apixaban in AF
-
-
-
-
At a glance: preventing cardiovascular thrombotic event after ACS
December 21, 2021Ticagrelor in preventing post-ACS thrombotic events
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
-
Ticagrelor Hub: when to use and which dose?
November 28, 2021The dosage and indications of Ticagrelor
-
Cardiometabolic Grand round, Session 5
November 21, 2021The 5th session of Cardiometabolic grand round
-
Save the date: Hypertension and hyperlipidemia academy, session 4
November 16, 2021The 4th session of Hypertension and hyperlipidemia academy
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Save the date: Cardiometabolic grand round, 5th session
November 8, 2021The 5th session of Cardiometabolic grand round program
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
Management of dyslipidemia in diabetic patients
October 24, 2021DLP and T2DM: approach and management
-
DiaBeat: The Beating Heart of Diabetes (8th session)
October 19, 20218th Diabetes Masterclass for Cardiologists
-
-
Save the date: Late-breaking Science in Cardiovascular disease prevention
October 19, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
Save the date; DiaBeat: The Beating Heart of Diabetes
October 9, 20218th Diabetes Masterclass for Cardiologists
-
-
Cardiopoint 13: Management of stage 1 hypertension in adults with low cardiovascular risk
September 25, 2021Stage 1 HTN in low risk patients
-
-
-
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
-
-
-
-
-
-
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
August 24, 2021Neprilysin Inhibitors to prevent LV remodeling post MI
-
The clinical landscape for Diabetes and Cardiovascular disease
August 24, 2021T2DM and cardiovascular diseases: The clinical landscape
-
-
-
Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial
August 22, 2021Midodrine in vasovagal syndrome prevention
-
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
August 21, 2021Impact of Dapagliflozin on the survival of HFrEF patients
-
Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial
August 15, 2021Milrinone vs. Dobutamine: DOREMI trial
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
Symptom matters: angina control in coronary artery disease
August 14, 2021From surrogates to symptom control in CAD
-
-
-
-
Save the date: The first Umbrella event: chronic coronary syndrome
August 8, 2021First Umbrella session: CCS
-
Finding the optimal thromboprophylaxis regimen in patients with COVID-19
August 4, 2021Preventing thromboembolic events in COVID-19
-
-
Save the date: Anti-thrombotic lighthouse: navigating a new path to CAD management
August 2, 2021Anti-thrombotic lighthouse, 3rd session: anti-thrombotic therapy in CAD Cardio Calendar
-
-
Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD
August 1, 20217th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention
-
-
Save the date: Finding the optimal thromboprophylaxis regimen in patients with COVID-19
July 31, 2021thromboprophylaxis in COVID-19
-
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
-
-
-
Save the date: Anti-Thrombotic Lighthouse (2nd session)
July 14, 20212nd session of Anti-Thrombotic Lighthouse: antiplatelet therapy in CCS
-
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Safety and Efficacy of different antithrombotic strategies after TAVI
July 11, 2021Post-TAVI antithrombotic strategies
-
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
July 5, 2021Diagnosis and management of Iron deficiency in HF patients
-
-
-
Cardio-Watch Podcast: Episode 4, Dyslipidemia
June 28, 2021The fourth episode of Cardio-Watch: Dyslipidemia
-
Save the date: Anti-Thrombotic Lighthouse (1st session)
June 26, 20211st session of Anti-Thrombotic Lighthouse: antiplatelet therapy in ACS
-
DiaBeat: The Beating Heart of Diabetes (6th session)
June 24, 20216th Diabetes Masterclass for Cardiologists
-
Cardiometabolic Grand Round: 4th session
June 24, 2021Guideline-directed cardiovascular evaluations before surgery
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
-
-
-
-
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
-
Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter
June 13, 2021The Third episode of Cardio-Watch: AF
-
Save the date; DiaBeat: The Beating Heart of Diabetes
June 8, 20216th Diabetes Masterclass for Cardiologists
-
A review on four landmark anti-platelet therapy trials
June 1, 2021The latest updates on anti-platelet therapy from 4 important trials
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
Cardiopoint 12: Two-Drug Combinations as First-Step Antihypertensive treatment
May 30, 2021Initial administration of two-drug combinations in HTN
-
Cardio-Watch podcast: Episode 2, Hypertension
May 29, 2021The second episode of Cardio-Watch: Hypertension
-
Aspirin vs Clopidogrel for chronic maintenance monotherapy after PCI
May 20, 2021The comparison of Clopidogrel and Aspirin monotherapy after PCI (HOST-EXAM trial)
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
Updates on the management of Diabetes and cardiometabolic disease
May 18, 2021Actoverco Diabetes Lunch Webinar
-
Impact: DAPT vs. Aspirin in patients with stroke or TIA
May 16, 2021A recent meta-analysis about antiplatelet therapy in stroke
-
The evolution of antiplatelet therapy in CAD: a 45 year journey
May 10, 2021A brief history of anti-platelet therapy in CAD
-
-
DiaBeat: The Beating Heart of Diabetes (5th session)
May 1, 20215th Diabetes Masterclass for Cardiologists
-
-
Save the date: Abidi Hypertension and Hyperlipidemia Academy
April 19, 2021Keeping up-to-date on HTN and DLP treatment
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
-
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
CardioPoint (11): Antithrombotic therapy in patients with AF treated with OAC undergoing PCI
March 11, 2021Quick Review of ACC 2020 Expert Consensus Pathway of Antithrombotic Management
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
10th Case: Drug Drug Interactions
January 21, 2021DOACs important interactions in clinical practice
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
-
-
Seventh Case: Thrombocytopenia
January 21, 2021Any Concerns for OACs Use in Patients with Thrombocytopenia
-
Sixth Case: Hepatic Impairment
January 21, 2021OAC of choice in patients with hepatic impairment, any difference between DOACs?
-
-
Forth Case: Extreme Body Weights
January 21, 2021OAC choice in patients with obesity or low body weights, any role for DOACs?
-
Third Case: AF & Artificial Heart Valves
January 21, 2021OAC of choice in patients with artificial heart valves
-
Second Case: Cancer associated VTE
January 21, 2021Anticoagulation of choice in patients with cancer, the importance of DDI
-
First Case: Elective PCI and AF
January 21, 2021Antithrombotic regimen of choice in patients with AF undergoing elective PCI
-
Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial
January 20, 2021Continue vs Stop of RAS inhibitors in patients with COVID-19
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: Residents’ Island; Abidi CVD Prevention Academy
January 1, 2021Multidisciplinary approach to CVD Prevention